Clinical Trial Update: Biomarkers for Outcomes In Late-life Depression (BOLD) [Phase 4]

View source ↗

Summary

This Clinical Trials update reports results from a Phase 4 study on biomarkers predicting outcomes in late-life major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED